Understanding how myeloid cells function in different tissue environments
Official title: Myeloid Cells: Roles in Different Tissue Microenvironments
Funded at Keystone Symposia · NIH-11072245 · Data updated 2026-11-12
This study is all about a conference where scientists will talk about how important immune cells called myeloid cells work in different parts of the body, and by sharing their findings, they hope to discover better treatments for diseases related to the immune system that could help patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Keystone Symposia NIH-funded |
| Lab location | 1 site (Silverthorne, United States) |
| Project start | November 12, 2024 |
| Project end | November 11, 2025 |
| Funding year | 2025 |
| Award (this year) | $3,400 |
| NIH project number | 1R13AI188934-01 |
| Project ID | NIH-11072245 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals with immune-related conditions or diseases influenced by myeloid cell function.
✕Less likely to help
Patients with conditions unrelated to immune system function may not receive any benefit from this research.
What this research studies
This research focuses on a conference that will explore the roles of myeloid cells, which are crucial components of the immune system, in various tissue microenvironments. The conference will bring together scientists to discuss how these cells interact with their surroundings and adapt to different conditions, including biochemical and biophysical influences. By integrating various scientific perspectives, the conference aims to foster collaboration and share the latest discoveries in the field. Patients may benefit from the advancements in understanding myeloid cells, which could lead to improved treatments for diseases involving the immune system.
Why it matters
Potential benefit: If successful, this research could lead to new insights that improve treatments for diseases related to the immune system.
How similar studies have gone: Previous conferences and research have successfully advanced understanding in related areas, indicating a strong potential for impactful outcomes.
Where this research is happening
-
Keystone Symposia
Silverthorne, United States Active
Researchers
- Principal investigator: Sheppard, Terry L. — Keystone Symposia
- Study coordinator: Sheppard, Terry L.
Related research
Other NIH-funded projects on the same topics.
-
Understanding how the immune system protects against malaria
This study is all about a conference where experts will share the latest ideas and discoveries on how our immune system fights malaria, which could lead to better treatments and vaccines for patients and families affected by this disease.
-
Innovative engineering approaches for organoid research
This conference is all about bringing together scientists to share new ideas on creating tiny lab-made organs, which can help us learn more about human health and improve treatments for diseases.
-
Exploring new ways to deliver drugs to the brain.
This study is all about a conference where experts are sharing new ideas on how to get medicines directly to the brain, which is really important for helping people with conditions like Alzheimer's and brain tumors.
-
Understanding how genetic variations affect human development and aging
This study is bringing together experts to talk about how having different genetic cells in the same person can affect our growth and aging, helping us learn more about how these variations might be connected to health and diseases.
-
Understanding the differences in tuberculosis from lab models to human cases
This study is all about a conference where scientists will come together to share ideas on how tuberculosis affects people differently and how treatments can be improved, with the hope of finding better ways to manage this serious disease.
-
Exploring new ways to use antibodies as treatments for various diseases
This study is all about a conference where experts will share new ideas on how to make antibody treatments better for diseases like cancer and autoimmune disorders, and they'll also talk about how technology can help improve these therapies, which could lead to better options for patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.